Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Market Recap Tech leads as consumer lags amid mild market slips FutureCrest FCRS CEO outlines postmerger growth strategy targets profitability and expanded market presence Smart SLGB Stock Buy or Sell 552 20260420 Vanguard Financials VFH 2026 Viability Assessment of the Admiral Share Class VFAIX for Sector Investors PRGS Progress shares climb 4 after reporting 298 YoY revenue growth signaling momentum in AI software offerings What Central Sec CET disclosed about cost pressures CET Earnings Central Sec Reports No Revenue Data RFIL RF Industries EPS surges 96 on 24 revenue growth but shares dip despite strong quarter NUCL Eagle management highlights rising clean energy demand as core longterm growth priority in quarterly earnings report Semtech Stock Surges After Chipmaker Beats Market Expectations UK Secures 37bn Trade Agreement with Six Gulf States Slashing 580m in Tariffs BlackBerry Positions Malaysia as Strategic Hub for Asian Cybersecurity Expansion Three Signs from APEC That US and China Remain Far Apart on Trade Lowes Companies Price Target Reduced by 32 at RBC Capital Chinas Lunar South Pole Mission Aims to Assess Resources for Future Base USCB Q1 2026 Earnings Earnings Beat Driven by Strong Net Interest Margin IMMR Q3 2025 Earnings EPS Surges Past Estimates Stock Reacts Positively BURU Q3 2023 Earnings Significant Loss Per Share Amid PreRevenue Stage VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Stock Declines Slightly NPO Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher NMFC Q1 2026 Earnings EPS Misses Estimates Slightly Stock Dips on Narrow Surprise BillionToOne Inc BLLN Surges 627 as Momentum Builds Toward Key Resistance Delek US Holdings DK Surges Over 25 as Stock Approaching Key Resistance Western Alliance Bancorporation Holds Steady Near 7859 as Consolidation Continues NervGen Pharma NGEN Dips 282 to 207 Approaching Key Support Outlook Therapeutics Surges 27 Assessing the Move and Key Levels for OTLK